ME Abu-Rmeileh, Niveen
Wahdan, Yasmeen
Mehrtash, Hedieh
Hamad, Khitam Abu
Awad, Arein
Tunçalp, Ӧzge
Funding for this research was provided by:
UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a cosponsored program executed by the World Health Organization (WHO). (Reference Number 2019/956088-0, Reference Number 2019/956088-0)
Article History
Received: 27 May 2022
Accepted: 30 November 2022
First Online: 22 December 2022
Declarations
:
: This study methodology and protocol were approved by the WHO Ethical Review Committee, WHO Review Panel on Research Projects, the Institute of Community and Public Health at the Birzeit University Ethics Research Committee, and the Helsinki Committee of the Ministry of Health. Informed consent was obtained from all participating women. Oral informed consent was obtained from women at the hospital to contact them within two to six weeks postpartum. Due to the Covid-19 lockdown and protective measures, we conducted phone interviews with women to reduce fieldworker mobility as it posed high risk for the team and the community. The interviewers obtained a second oral informed consent from women to conduct telephone interview after they agreed to participate in the study. Oral informed consent was approved by the WHO ethics Review Committee and ICPH Ethics Review Committee. The study was carried out in accordance with the relevant guidelines and regulations. The study did not include women less than 18 years old and hence informed consent was obtained from the legally authorized representative or the legal guardian was not required.
: Not applicable.
: The authors declare that they have no competing interests.